UPDATE 1-Idera says drug safe, well tolerated in skin disease study

March 28 (Reuters) - Idera Pharmaceuticals Inc said its lead experimental drug for the most common form of psoriasis was found to be safe and well tolerated by patients after 12 weeks of treatment in...

from Reuters: Hot Stocks http://ift.tt/1frZPmp